Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Schmalzing

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Arthritis Care & Research|March 19, 2016
Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid ArthritisEva C Scharbatke, Frank Behrens, Marc Schmalzing, et al.
Medicine|May 9, 2020
Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumabMarc Schmalzing, Frank Behrens, Eva C Schwaneck, et al.
Rheumatology (Oxford, England)|July 17, 2018
Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumabFrank Behrens, Michaela Koehm, Eva C Schwaneck, et al.
BMC Rheumatology|December 24, 2019
Use of a "critical difference" statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritisFrank Behrens, Michaela Koehm, Eva C Schwaneck, et al.
Clinical Rheumatology|March 25, 2020
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort studyFrank Behrens, Hans-Peter Tony, Michaela Koehm, et al.
Frontiers in Immunology|July 17, 2020
Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune EncephalitisMatthias Froehlich, Eva C Schwaneck, Michael Gernert, et al.
JMIR Mhealth and Uhealth|May 29, 2026
Patient-Centered Lupus Erythematosus Mobile Apps: Systematic Search and Cross-Sectional Evaluation by Patients and PhysiciansTassilo Dege, Antonia Ullmann, Caroline Glatzel, et al.
Rheumatology International|October 25, 2021
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medicationMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
Rheumatology (Oxford, England)|January 25, 2014
Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestationsJoerg C Henes, Ina Koetter, Marius Horger, et al.
Rheumatology (Oxford, England)|June 3, 2017
Toxic drug-induced liver failure during therapy of rheumatoid arthritis with tocilizumab subcutaneously: a case reportFriedrich Anger, Armin Wiegering, Johanna Wagner, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Arthritis Care & Research|March 19, 2016
Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid ArthritisEva C Scharbatke, Frank Behrens, Marc Schmalzing, et al.
Medicine|May 9, 2020
Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumabMarc Schmalzing, Frank Behrens, Eva C Schwaneck, et al.
Rheumatology (Oxford, England)|July 17, 2018
Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumabFrank Behrens, Michaela Koehm, Eva C Schwaneck, et al.
BMC Rheumatology|December 24, 2019
Use of a "critical difference" statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritisFrank Behrens, Michaela Koehm, Eva C Schwaneck, et al.
Clinical Rheumatology|March 25, 2020
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort studyFrank Behrens, Hans-Peter Tony, Michaela Koehm, et al.
Frontiers in Immunology|July 17, 2020
Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune EncephalitisMatthias Froehlich, Eva C Schwaneck, Michael Gernert, et al.
JMIR Mhealth and Uhealth|May 29, 2026
Patient-Centered Lupus Erythematosus Mobile Apps: Systematic Search and Cross-Sectional Evaluation by Patients and PhysiciansTassilo Dege, Antonia Ullmann, Caroline Glatzel, et al.
Rheumatology International|October 25, 2021
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medicationMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
Rheumatology (Oxford, England)|January 25, 2014
Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestationsJoerg C Henes, Ina Koetter, Marius Horger, et al.
Rheumatology (Oxford, England)|June 3, 2017
Toxic drug-induced liver failure during therapy of rheumatoid arthritis with tocilizumab subcutaneously: a case reportFriedrich Anger, Armin Wiegering, Johanna Wagner, et al.
Pageof 14